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SUMMARY. A selective and sensitive liquid chromatography-tandem mass spectrometry method was de-
veloped and validated for quantitation of bupropion (BUP) and its metabolite hydroxybupropion (HBUP)
in rat plasma and urine using carbamazepine as an internal standard. Chromatographic separation was
achieved on a SB-C18 column at 30 °C, using the gradient elution of 0.1 % formic acid in water and ace-
tonitrile. Calibration plots were linear over range of 10-2000 ng/mL for BUP and 5-1000 ng/mL for HBUP
in rat plasma. The intra- and inter-run relative standard deviations of the assay were less than 10 % for
both BUP and HBUP. The effects of tolbutamide on cytochrome P450-mediated metabolism of BUP were
studied by the validated method above. The results revealed that tolbutamide had signigicantly decreased
the rate of BUP hydroxylation. 
